Market Access What India can learn from Kinvard Bio India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.
R&D AI can help us build a new, more precise, antibiotic pipelin... AI has begun to influence early-stage antibiotic discovery by identifying novel antibacterial compounds that are difficult to uncover traditionally.
News EU invests €30m to fight antimicrobial resistance The EU has pledged €30m in funding for countermeasures to antimicrobial resistance, earmarked for the discovery and development of new antibacterials.
R&D Europe has the tools to fight superbugs. Let’s use them. Data shows countries are off track – increasing the risk of profound health and economic consequences from AMR. Medical technologies can help.
R&D Sponsored Why conditions like UTI call for new antibiotics Exploring the growing threat of UTIs, the need for new antibiotics, and GSK’s role in advancing targeted treatments.
R&D Why I'm focused on the trillion-dollar AMR crisis everyone's... AMR demands sustained commitment beyond conventional market incentives.
News ESC26: Isomab safety evidence on blood vessel growth for CAD Isomab has presented landmark safety data at ESC, clearing the path for next-generation therapies to promote blood vessel growth in CAD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
